{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:10:17Z","timestamp":1793329817765,"version":"4.5.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100721"],"award-info":[{"award-number":["82100721"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100615"],"award-info":[{"award-number":["82100615"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M710686"],"award-info":[{"award-number":["2022M710686"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation of Jiangsu Commission of Health","award":["M2021048"],"award-info":[{"award-number":["M2021048"]}]},{"name":"Project of Taizhou Clinical Medical School of Nanjing Medical University","award":["TZKY20220209"],"award-info":[{"award-number":["TZKY20220209"]}]},{"name":"Young Scholars of Yangtze River Scholar Professor Program","award":["2024 WB"],"award-info":[{"award-number":["2024 WB"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-024-01922-1","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T04:04:34Z","timestamp":1732161874000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["The gut microbiome, chronic kidney disease, and sarcopenia"],"prefix":"10.1186","volume":"22","author":[{"given":"Guohao","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan H.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"key":"1922_CR1","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41581-021-00498-0","volume":"18","author":"XH Wang","year":"2022","unstructured":"Wang XH, Mitch WE, Price SR. Pathophysiological mechanisms leading to muscle loss in chronic kidney disease. Nat Rev Nephrol. 2022;18:138\u201352.","journal-title":"Nat Rev Nephrol"},{"key":"1922_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruy\u00e8re O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16\u201331.","journal-title":"Age Ageing"},{"key":"1922_CR3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/MCO.0000000000000871","volume":"25","author":"SM Barreto","year":"2022","unstructured":"Barreto SM, Picard K, Klein M. Sarcopenia and sarcopenic obesity in chronic kidney disease: update on prevalence, outcomes, risk factors and nutrition treatment. Curr Opin Clin Nutr. 2022;25:371\u20137.","journal-title":"Curr Opin Clin Nutr"},{"key":"1922_CR4","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.3390\/nu14194077","volume":"14","author":"W Wathanavasin","year":"2022","unstructured":"Wathanavasin W, Banjongjit A, Avihingsanon Y, Praditpornsilpa K, Tungsanga K, Eiam-Ong S, et al. Prevalence of Sarcopenia and its impact on cardiovascular events and mortality among dialysis patients: a systematic review and meta-analysis. Nutrients. 2022;14:4077.","journal-title":"Nutrients"},{"key":"1922_CR5","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.clnu.2022.03.025","volume":"41","author":"HS Ribeiro","year":"2022","unstructured":"Ribeiro HS, Neri S, Oliveira JS, Bennett PN, Viana JL, Lima RM. Association between Sarcopenia and clinical outcomes in chronic kidney disease patients: a systematic review and meta-analysis. Clin Nutr. 2022;41:1131\u201340.","journal-title":"Clin Nutr"},{"key":"1922_CR6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.nut.2018.12.005","volume":"62","author":"S Lai","year":"2019","unstructured":"Lai S, Muscaritoli M, Andreozzi P, Sgreccia A, De Leo S, Mazzaferro S, et al. Sarcopenia and cardiovascular risk indices in patients with chronic kidney disease on conservative and replacement therapy. Nutrition. 2019;62:108\u201314.","journal-title":"Nutrition"},{"key":"1922_CR7","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/jcsm.13331","volume":"14","author":"MJ Sheng","year":"2023","unstructured":"Sheng MJ, Cao JY, Hou SM, Li M, Wang Y, Fang Q, et al. Computed tomography-determined skeletal muscle density predicts 3-year mortality in initial-dialysis patients in China. J Cachexia Sarcopenia Muscle. 2023;14:2569\u201378.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1922_CR8","doi-asserted-by":"publisher","first-page":"16550","DOI":"10.1038\/s41598-022-20450-x","volume":"12","author":"J Zheng","year":"2022","unstructured":"Zheng J, Yin Q, Wang SY, Wang YY, Xiao JJ, Tang TT, et al. Ultrasound-assessed diaphragm dysfunction predicts clinical outcomes in hemodialysis patients. Sci Rep-Uk. 2022;12:16550.","journal-title":"Sci Rep-Uk"},{"key":"1922_CR9","doi-asserted-by":"publisher","first-page":"19382","DOI":"10.1038\/s41598-019-56035-4","volume":"9","author":"B Wang","year":"2019","unstructured":"Wang B, Yin Q, Wang YY, Tu Y, Han Y, Gao M, et al. Diaphragmatic dysfunction associates with dyspnoea, fatigue, and hiccup in haemodialysis patients: a cross-sectional study. Sci Rep-Uk. 2019;9:19382.","journal-title":"Sci Rep-Uk"},{"key":"1922_CR10","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1002\/jcsm.12839","volume":"12","author":"O Gungor","year":"2021","unstructured":"Gungor O, Ulu S, Hasbal NB, Anker SD, Kalantar-Zadeh K. Effects of hormonal changes on Sarcopenia in chronic kidney disease: where are we now and what can we do? J Cachexia Sarcopenia Muscle. 2021;12:1380\u201392.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1922_CR11","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1681\/ASN.2004100842","volume":"17","author":"JL Bailey","year":"2006","unstructured":"Bailey JL, Zheng B, Hu Z, Price SR, Mitch WE. Chronic kidney disease causes defects in signaling through the insulin receptor substrate\/phosphatidylinositol 3-kinase\/AKT pathway: implications for muscle atrophy. J Am Soc Nephrol. 2006;17:1388\u201394.","journal-title":"J Am Soc Nephrol"},{"key":"1922_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/jcsm.13112","volume":"14","author":"Y Huang","year":"2023","unstructured":"Huang Y, Wang B, Hassounah F, Price SR, Klein J, Mohamed T, et al. The impact of senescence on muscle wasting in chronic kidney disease. J Cachexia Sarcopenia Muscle. 2023;14:126\u201341.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1922_CR13","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s40620-022-01560-1","volume":"36","author":"F Mart\u00edn-Del-Campo","year":"2023","unstructured":"Mart\u00edn-Del-Campo F, Avesani CM, Stenvinkel P, Lindholm B, Cueto-Manzano AM, Cort\u00e9s-Sanabria L. Gut microbiota disturbances and protein-energy wasting in chronic kidney disease: a narrative review. J Nephrol. 2023;36:873\u201383.","journal-title":"J Nephrol"},{"key":"1922_CR14","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3390\/toxins13070472","volume":"13","author":"E Margiotta","year":"2021","unstructured":"Margiotta E, Caldiroli L, Callegari ML, Miragoli F, Zanoni F, Armelloni S, et al. Association of Sarcopenia and gut microbiota composition in older patients with advanced chronic kidney disease, investigation of the interactions with uremic toxins, inflammation and oxidative stress. Toxins. 2021;13:472.","journal-title":"Toxins"},{"key":"1922_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/nu12010106","volume":"12","author":"MS Lustgarten","year":"2020","unstructured":"Lustgarten MS. The kidney-gut-muscle axis in end-stage renal disease is similarly represented in older adults. Nutrients. 2020;12:106.","journal-title":"Nutrients"},{"key":"1922_CR16","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1093\/ndt\/gfaa076","volume":"35","author":"K Uchiyama","year":"2020","unstructured":"Uchiyama K, Wakino S, Irie J, Miyamoto J, Matsui A, Tajima T, et al. Contribution of uremic dysbiosis to insulin resistance and sarcopenia. Nephrol Dial Transpl. 2020;35:1501\u201317.","journal-title":"Nephrol Dial Transpl"},{"key":"1922_CR17","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s40620-020-00840-y","volume":"34","author":"A Sabatino","year":"2021","unstructured":"Sabatino A, Cuppari L, Stenvinkel P, Lindholm B, Avesani CM. Sarcopenia in chronic kidney disease: what have we learned so far? J Nephrol. 2021;34:1347\u201372.","journal-title":"J Nephrol"},{"key":"1922_CR18","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ki.2012.345","volume":"83","author":"ND Vaziri","year":"2013","unstructured":"Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, DeSantis TZ, et al. Chronic kidney disease alters intestinal microbial flora. Kidney Int. 2013;83:308\u201315.","journal-title":"Kidney Int"},{"key":"1922_CR19","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1111\/jcmm.16230","volume":"25","author":"L Yin","year":"2021","unstructured":"Yin L, Li X, Ghosh S, Xie C, Chen J, Huang H. Role of gut microbiota-derived metabolites on vascular calcification in CKD. J Cell Mol Med. 2021;25:1332\u201341.","journal-title":"J Cell Mol Med"},{"key":"1922_CR20","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/MNH.0b013e328358c8d5","volume":"21","author":"ND Vaziri","year":"2012","unstructured":"Vaziri ND. CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity. Curr Opin Nephrol Hy. 2012;21:587\u201392.","journal-title":"Curr Opin Nephrol Hy"},{"key":"1922_CR21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000360010","volume":"39","author":"J Wong","year":"2014","unstructured":"Wong J, Piceno YM, DeSantis TZ, Pahl M, Andersen GL, Vaziri ND. Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. Am J Nephrol. 2014;39:230\u20137.","journal-title":"Am J Nephrol"},{"key":"1922_CR22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.nefro.2016.05.008","volume":"37","author":"GS Cigarran","year":"2017","unstructured":"Cigarran GS, Gonz\u00e1lez PE, Cases AA. Gut microbiota in chronic kidney disease. Nefrologia. 2017;37:9\u201319.","journal-title":"Nefrologia"},{"key":"1922_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1080\/0886022X.2020.1864404","volume":"43","author":"J Zhao","year":"2021","unstructured":"Zhao J, Ning X, Liu B, Dong R, Bai M, Sun S. Specific alterations in gut microbiota in patients with chronic kidney disease: an updated systematic review. Ren Fail. 2021;43:102\u201312.","journal-title":"Ren Fail"},{"key":"1922_CR24","first-page":"1401","volume":"38","author":"YE Guirong","year":"2018","unstructured":"Guirong YE, Minjie Z, Lixin YU, Junsheng YE, Lin Y, Lisha S. Gut microbiota in renal transplant recipients, patients with chronic kidney disease and healthy subjects. Nan Fang Yi Ke Da Xue Xue Bao. 2018;38:1401\u20138.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"1922_CR25","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1136\/gutjnl-2019-319766","volume":"69","author":"X Wang","year":"2020","unstructured":"Wang X, Yang S, Li S, Zhao L, Hao Y, Qin J, et al. Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents. Gut. 2020;69:2131\u201342.","journal-title":"Gut"},{"key":"1922_CR26","doi-asserted-by":"publisher","first-page":"e228530","DOI":"10.1371\/journal.pone.0228530","volume":"15","author":"E Margiotta","year":"2020","unstructured":"Margiotta E, Miragoli F, Callegari ML, Vettoretti S, Caldiroli L, Meneghini M, et al. Gut microbiota composition and frailty in elderly patients with chronic kidney disease. PLoS ONE. 2020;15:e228530.","journal-title":"PLoS ONE"},{"key":"1922_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40168-022-01443-4","volume":"11","author":"H Wang","year":"2023","unstructured":"Wang H, Ainiwaer A, Song Y, Qin L, Peng A, Bao H, et al. Perturbed gut microbiome and fecal and serum metabolomes are associated with chronic kidney disease severity. Microbiome. 2023;11:3.","journal-title":"Microbiome"},{"key":"1922_CR28","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1042\/CS20190171","volume":"133","author":"S Wang","year":"2019","unstructured":"Wang S, Lv D, Jiang S, Jiang J, Liang M, Hou F, et al. Quantitative reduction in short-chain fatty acids, especially butyrate, contributes to the progression of chronic kidney disease. Clin Sci. 2019;133:1857\u201370.","journal-title":"Clin Sci"},{"key":"1922_CR29","doi-asserted-by":"publisher","first-page":"2186685","DOI":"10.1080\/19490976.2023.2186685","volume":"15","author":"BA Peters","year":"2023","unstructured":"Peters BA, Qi Q, Usyk M, Daviglus ML, Cai J, Franceschini N, et al. Association of the gut microbiome with kidney function and damage in the Hispanic Community Health Study\/Study of Latinos (HCHS\/SOL). Gut Microbes. 2023;15:2186685.","journal-title":"Gut Microbes"},{"key":"1922_CR30","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1093\/ndt\/gfaa122","volume":"36","author":"N Sato","year":"2021","unstructured":"Sato N, Kakuta M, Hasegawa T, Yamaguchi R, Uchino E, Murashita K, et al. Metagenomic profiling of gut microbiome in early chronic kidney disease. Nephrol Dial Transpl. 2021;36:1675\u201384.","journal-title":"Nephrol Dial Transpl"},{"key":"1922_CR31","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s13059-023-03056-y","volume":"24","author":"P Zhang","year":"2023","unstructured":"Zhang P, Wang X, Li S, Cao X, Zou J, Fang Y, et al. Metagenome-wide analysis uncovers gut microbial signatures and implicates taxon-specific functions in end-stage renal disease. Genome Biol. 2023;24:226.","journal-title":"Genome Biol"},{"key":"1922_CR32","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1681\/ASN.2010121220","volume":"22","author":"PA Aronov","year":"2011","unstructured":"Aronov PA, Luo FJ, Plummer NS, Quan Z, Holmes S, Hostetter TH, et al. Colonic contribution to uremic solutes. J Am Soc Nephrol. 2011;22:1769\u201376.","journal-title":"J Am Soc Nephrol"},{"key":"1922_CR33","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1681\/ASN.2013080905","volume":"25","author":"A Ramezani","year":"2014","unstructured":"Ramezani A, Raj DS. The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol. 2014;25:657\u201370.","journal-title":"J Am Soc Nephrol"},{"key":"1922_CR34","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3390\/toxins13040252","volume":"13","author":"J Rysz","year":"2021","unstructured":"Rysz J, Franczyk B, \u0141awi\u0144ski J, Olszewski R, Cia\u0142kowska-Rysz A, Gluba-Brz\u00f3zka A. The impact of CKD on uremic toxins and gut microbiota. Toxins. 2021;13:252.","journal-title":"Toxins"},{"key":"1922_CR35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11883-020-00892-2","volume":"22","author":"H Liu","year":"2020","unstructured":"Liu H, Zhuang J, Tang P, Li J, Xiong X, Deng H. The role of the gut microbiota in coronary heart disease. Curr Atheroscler Rep. 2020;22:77.","journal-title":"Curr Atheroscler Rep"},{"key":"1922_CR36","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1080\/0886022X.2021.1944875","volume":"43","author":"X Xu","year":"2021","unstructured":"Xu X, Wang H, Guo D, Man X, Liu J, Li J, et al. Curcumin modulates gut microbiota and improves renal function in rats with uric acid nephropathy. Ren Fail. 2021;43:1063\u201375.","journal-title":"Ren Fail"},{"key":"1922_CR37","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1373\/clinchem.2006.076711","volume":"53","author":"A Meinitzer","year":"2007","unstructured":"Meinitzer A, Seelhorst U, Wellnitz B, Halwachs-Baumann G, Boehm BO, Winkelmann BR, et al. Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study). Clin Chem. 2007;53:273\u201383.","journal-title":"Clin Chem"},{"key":"1922_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.trsl.2020.08.007","volume":"228","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Wang Y, Ke B, Du J. TMAO: how gut microbiota contributes to heart failure. Transl Res. 2021;228:109\u201325.","journal-title":"Transl Res"},{"key":"1922_CR39","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/toxins9020052","volume":"9","author":"T Gryp","year":"2017","unstructured":"Gryp T, Vanholder R, Vaneechoutte M, Glorieux G. p-Cresyl Sulfate. Toxins. 2017;9:52.","journal-title":"Toxins"},{"key":"1922_CR40","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.coi.2021.02.006","volume":"70","author":"M Qayed","year":"2021","unstructured":"Qayed M, Michonneau D, Soci\u00e9 G, Waller EK. Indole derivatives, microbiome and graft versus host disease. Curr Opin Immunol. 2021;70:40\u20137.","journal-title":"Curr Opin Immunol"},{"key":"1922_CR41","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1038\/s41467-018-05470-4","volume":"9","author":"HM Roager","year":"2018","unstructured":"Roager HM, Licht TR. Microbial tryptophan catabolites in health and disease. Nat Commun. 2018;9:3294.","journal-title":"Nat Commun"},{"key":"1922_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.coi.2020.12.004","volume":"70","author":"T Zelante","year":"2021","unstructured":"Zelante T, Puccetti M, Giovagnoli S, Romani L. Regulation of host physiology and immunity by microbial indole-3-aldehyde. Curr Opin Immunol. 2021;70:27\u201332.","journal-title":"Curr Opin Immunol"},{"key":"1922_CR43","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/mnfr.201200594","volume":"57","author":"WR Russell","year":"2013","unstructured":"Russell WR, Duncan SH, Scobbie L, Duncan G, Cantlay L, Calder AG, et al. Major phenylpropanoid-derived metabolites in the human gut can arise from microbial fermentation of protein. Mol Nutr Food Res. 2013;57:523\u201335.","journal-title":"Mol Nutr Food Res"},{"key":"1922_CR44","doi-asserted-by":"publisher","first-page":"17647","DOI":"10.1038\/s41598-020-74673-x","volume":"10","author":"J Yabuuchi","year":"2020","unstructured":"Yabuuchi J, Ueda S, Yamagishi SI, Nohara N, Nagasawa H, Wakabayashi K, et al. Association of advanced glycation end products with Sarcopenia and frailty in chronic kidney disease. Sci Rep-Uk. 2020;10:17647.","journal-title":"Sci Rep-Uk"},{"key":"1922_CR45","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/ejcn.2012.220","volume":"67","author":"NJ Kellow","year":"2013","unstructured":"Kellow NJ, Savige GS. Dietary advanced glycation end-product restriction for the attenuation of insulin resistance, oxidative stress and endothelial dysfunction: a systematic review. Eur J Clin Nutr. 2013;67:239\u201348.","journal-title":"Eur J Clin Nutr"},{"key":"1922_CR46","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3390\/toxins14100648","volume":"14","author":"S Bhargava","year":"2022","unstructured":"Bhargava S, Merckelbach E, Noels H, Vohra A, Jankowski J. Homeostasis in the gut microbiota in chronic kidney disease. Toxins. 2022;14:648.","journal-title":"Toxins"},{"key":"1922_CR47","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/advances\/nmz028","volume":"10","author":"S Chung","year":"2019","unstructured":"Chung S, Barnes JL, Astroth KS. Gastrointestinal microbiota in patients with chronic kidney disease: a systematic review. Adv Nutr. 2019;10:888\u2013901.","journal-title":"Adv Nutr"},{"key":"1922_CR48","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1084\/jem.20181639","volume":"216","author":"MT Sorbara","year":"2019","unstructured":"Sorbara MT, Dubin K, Littmann ER, Moody TU, Fontana E, Seok R, et al. Inhibiting antibiotic-resistant Enterobacteriaceae by microbiota-mediated intracellular acidification. J Exp Med. 2019;216:84\u201398.","journal-title":"J Exp Med"},{"key":"1922_CR49","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1093\/ndt\/gfu287","volume":"30","author":"A Sabatino","year":"2015","unstructured":"Sabatino A, Regolisti G, Brusasco I, Cabassi A, Morabito S, Fiaccadori E. Alterations of intestinal barrier and microbiota in chronic kidney disease. Nephrol Dial Transpl. 2015;30:924\u201333.","journal-title":"Nephrol Dial Transpl"},{"key":"1922_CR50","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1080\/10408398.2020.1761771","volume":"61","author":"M Ondrussek-Sekac","year":"2021","unstructured":"Ondrussek-Sekac M, Navas-Carrillo D, Orenes-Pi\u00f1ero E. Intestinal microbiota alterations in chronic kidney disease and the influence of dietary components. Crit Rev Food Sci. 2021;61:1490\u2013502.","journal-title":"Crit Rev Food Sci"},{"key":"1922_CR51","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/ki.2011.445","volume":"81","author":"CY Sun","year":"2012","unstructured":"Sun CY, Chang SC, Wu MS. Suppression of klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation. Kidney Int. 2012;81:640\u201350.","journal-title":"Kidney Int"},{"key":"1922_CR52","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/ki.2012.448","volume":"83","author":"H Watanabe","year":"2013","unstructured":"Watanabe H, Miyamoto Y, Honda D, Tanaka H, Wu Q, Endo M, et al. p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase. Kidney Int. 2013;83:582\u201392.","journal-title":"Kidney Int"},{"key":"1922_CR53","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.lfs.2012.01.013","volume":"90","author":"H Shimizu","year":"2012","unstructured":"Shimizu H, Bolati D, Higashiyama Y, Nishijima F, Shimizu K, Niwa T. Indoxyl sulfate upregulates renal expression of MCP-1 via production of ROS and activation of NF-\u03baB, p53, ERK, and JNK in proximal tubular cells. Life Sci. 2012;90:525\u201330.","journal-title":"Life Sci"},{"key":"1922_CR54","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.lfs.2012.11.012","volume":"92","author":"H Shimizu","year":"2013","unstructured":"Shimizu H, Yisireyili M, Higashiyama Y, Nishijima F, Niwa T. Indoxyl sulfate upregulates renal expression of ICAM-1 via production of ROS and activation of NF-\u03baB and p53 in proximal tubular cells. Life Sci. 2013;92:143\u20138.","journal-title":"Life Sci"},{"key":"1922_CR55","doi-asserted-by":"publisher","first-page":"e34026","DOI":"10.1371\/journal.pone.0034026","volume":"7","author":"CY Sun","year":"2012","unstructured":"Sun CY, Chang SC, Wu MS. Uremic toxins induce kidney fibrosis by activating intrarenal renin-angiotensin-aldosterone system associated epithelial-to-mesenchymal transition. PLoS ONE. 2012;7:e34026.","journal-title":"PLoS ONE"},{"key":"1922_CR56","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1681\/ASN.2013101062","volume":"25","author":"R Vanholder","year":"2014","unstructured":"Vanholder R, Schepers E, Pletinck A, Nagler EV, Glorieux G. The uremic toxicity of indoxyl sulfate and p-Cresyl sulfate: a systematic review. J Am Soc Nephrol. 2014;25:1897\u2013907.","journal-title":"J Am Soc Nephrol"},{"key":"1922_CR57","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.tem.2020.02.012","volume":"31","author":"Y Liu","year":"2020","unstructured":"Liu Y, Hou Y, Wang G, Zheng X, Hao H. Gut microbial metabolites of aromatic amino acids as signals in host-microbe interplay. Trends Endocrin Met. 2020;31:818\u201334.","journal-title":"Trends Endocrin Met"},{"key":"1922_CR58","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/ndt\/gfy238","volume":"34","author":"A Gonzalez","year":"2019","unstructured":"Gonzalez A, Krieg R, Massey HD, Carl D, Ghosh S, Gehr T, et al. Sodium butyrate ameliorates insulin resistance and renal failure in CKD rats by modulating intestinal permeability and mucin expression. Nephrol Dial Transpl. 2019;34:783\u201394.","journal-title":"Nephrol Dial Transpl"},{"key":"1922_CR59","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.3390\/microorganisms8121862","volume":"8","author":"R Ikee","year":"2020","unstructured":"Ikee R, Sasaki N, Yasuda T, Fukazawa S. Chronic kidney disease, gut dysbiosis, and constipation: a burdensome triplet. Microorganisms. 2020;8:1862.","journal-title":"Microorganisms"},{"key":"1922_CR60","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.2215\/CJN.03980609","volume":"4","author":"FC Barreto","year":"2009","unstructured":"Barreto FC, Barreto DV, Liabeuf S, Meert N, Glorieux G, Temmar M, et al. Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephro. 2009;4:1551\u20138.","journal-title":"Clin J Am Soc Nephro"},{"key":"1922_CR61","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/sj.ki.5002097","volume":"71","author":"T Nii-Kono","year":"2007","unstructured":"Nii-Kono T, Iwasaki Y, Uchida M, Fujieda A, Hosokawa A, Motojima M, et al. Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells. Kidney Int. 2007;71:738\u201343.","journal-title":"Kidney Int"},{"key":"1922_CR62","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/labinvest.2011.114","volume":"91","author":"CK Chiang","year":"2011","unstructured":"Chiang CK, Tanaka T, Inagi R, Fujita T, Nangaku M. Indoxyl sulfate, a representative uremic toxin, suppresses erythropoietin production in a HIF-dependent manner. Lab Invest. 2011;91:1564\u201371.","journal-title":"Lab Invest"},{"key":"1922_CR63","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41581-018-0018-2","volume":"14","author":"T Yang","year":"2018","unstructured":"Yang T, Richards EM, Pepine CJ, Raizada MK. The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease. Nat Rev Nephrol. 2018;14:442\u201356.","journal-title":"Nat Rev Nephrol"},{"key":"1922_CR64","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1161\/HYPERTENSIONAHA.124.21721","volume":"81","author":"DJ Durgan","year":"2024","unstructured":"Durgan DJ, Zubcevic J, Vijay-Kumar M, Yang T, Manandhar I, Aryal S, et al. Prospects for leveraging the microbiota as medicine for hypertension. Hypertension. 2024;81:951\u201363.","journal-title":"Hypertension"},{"key":"1922_CR65","doi-asserted-by":"publisher","first-page":"8946","DOI":"10.3390\/ijms21238946","volume":"21","author":"A Ticinesi","year":"2020","unstructured":"Ticinesi A, Mancabelli L, Tagliaferri S, Nouvenne A, Milani C, Del RD, et al. The gut-muscle axis in older subjects with low muscle mass and performance: a proof of concept study exploring fecal microbiota composition and function with shotgun metagenomics sequencing. Int J Mol Sci. 2020;21:8946.","journal-title":"Int J Mol Sci"},{"key":"1922_CR66","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.3390\/nu11071633","volume":"11","author":"A Ticinesi","year":"2019","unstructured":"Ticinesi A, Nouvenne A, Cerundolo N, Catania P, Prati B, Tana C, et al. Gut microbiota, muscle mass and function in aging: a focus on physical frailty and sarcopenia. Nutrients. 2019;11:1633.","journal-title":"Nutrients"},{"key":"1922_CR67","doi-asserted-by":"publisher","first-page":"eaan5662","DOI":"10.1126\/scitranslmed.aan5662","volume":"11","author":"S Lahiri","year":"2019","unstructured":"Lahiri S, Kim H, Garcia-Perez I, Reza MM, Martin KA, Kundu P, et al. The gut microbiota influences skeletal muscle mass and function in mice. Sci Transl Med. 2019;11:eaan5662.","journal-title":"Sci Transl Med"},{"key":"1922_CR68","doi-asserted-by":"publisher","first-page":"e1900603","DOI":"10.1002\/mnfr.201900603","volume":"63","author":"Y Ni","year":"2019","unstructured":"Ni Y, Yang X, Zheng L, Wang Z, Wu L, Jiang J, et al. Lactobacillus and bifidobacterium improves physiological function and cognitive ability in aged mice by the regulation of gut microbiota. Mol Nutr Food Res. 2019;63:e1900603.","journal-title":"Mol Nutr Food Res"},{"key":"1922_CR69","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/nu12010065","volume":"12","author":"A Picca","year":"2019","unstructured":"Picca A, Ponziani FR, Calvani R, Marini F, Biancolillo A, Coelho-Junior HJ, et al. Gut microbial, inflammatory and metabolic signatures in older people with physical frailty and sarcopenia: results from the biosphere study. Nutrients. 2019;12:65.","journal-title":"Nutrients"},{"key":"1922_CR70","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1002\/jcsm.13037","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang Y, Lane NE, Wu J, Yang T, Li J, et al. Population-based metagenomics analysis reveals altered gut microbiome in Sarcopenia: data from the Xiangya Sarcopenia Study. J Cachexia Sarcopenia Muscle. 2022;13:2340\u201351.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1922_CR71","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.clnu.2022.05.008","volume":"41","author":"DS Han","year":"2022","unstructured":"Han DS, Wu WK, Liu PY, Yang YT, Hsu HC, Kuo CH, et al. Differences in the gut microbiome and reduced fecal butyrate in elders with low skeletal muscle mass. Clin Nutr. 2022;41:1491\u2013500.","journal-title":"Clin Nutr"},{"key":"1922_CR72","doi-asserted-by":"publisher","first-page":"110722","DOI":"10.1016\/j.exger.2019.110722","volume":"127","author":"RA Fielding","year":"2019","unstructured":"Fielding RA, Reeves AR, Jasuja R, Liu C, Barrett BB, Lustgarten MS. Muscle strength is increased in mice that are colonized with microbiota from high-functioning older adults. Exp Gerontol. 2019;127:110722.","journal-title":"Exp Gerontol"},{"key":"1922_CR73","doi-asserted-by":"publisher","first-page":"127462","DOI":"10.1016\/j.micres.2023.127462","volume":"275","author":"SY Lee","year":"2023","unstructured":"Lee SY, Kim JH, Lee DY, Hur SJ. Characterization of gut microbiota in mouse models of aging and sarcopenia. Microbiol Res. 2023;275:127462.","journal-title":"Microbiol Res"},{"key":"1922_CR74","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3390\/nu9121303","volume":"9","author":"A Ticinesi","year":"2017","unstructured":"Ticinesi A, Lauretani F, Milani C, Nouvenne A, Tana C, Del RD, et al. Aging gut microbiota at the cross-road between nutrition, physical frailty, and Sarcopenia: is there a gut-muscle axis? Nutrients. 2017;9:1303.","journal-title":"Nutrients"},{"key":"1922_CR75","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/s41598-018-35228-3","volume":"9","author":"B Sovran","year":"2019","unstructured":"Sovran B, Hugenholtz F, Elderman M, Van Beek AA, Graversen K, Huijskes M, et al. Age-associated impairment of the mucus barrier function is associated with profound changes in microbiota and immunity. Sci Rep-Uk. 2019;9:1437.","journal-title":"Sci Rep-Uk"},{"key":"1922_CR76","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s11357-018-0026-y","volume":"40","author":"TW Buford","year":"2018","unstructured":"Buford TW, Carter CS, VanDerPol WJ, Chen D, Lefkowitz EJ, Eipers P, et al. Composition and richness of the serum microbiome differ by age and link to systemic inflammation. Geroscience. 2018;40:257\u201368.","journal-title":"Geroscience"},{"key":"1922_CR77","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","volume":"15","author":"L Ferrucci","year":"2018","unstructured":"Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15:505\u201322.","journal-title":"Nat Rev Cardiol"},{"key":"1922_CR78","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/j.1365-2672.1990.tb01575.x","volume":"69","author":"GR Gibson","year":"1990","unstructured":"Gibson GR. Physiology and ecology of the sulphate-reducing bacteria. J Appl Bacteriol. 1990;69:769\u201397.","journal-title":"J Appl Bacteriol"},{"key":"1922_CR79","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1158\/1541-7786.MCR-06-0439","volume":"5","author":"MS Attene-Ramos","year":"2007","unstructured":"Attene-Ramos MS, Wagner ED, Gaskins HR, Plewa MJ. Hydrogen sulfide induces direct radical-associated DNA damage. Mol Cancer Res. 2007;5:455\u20139.","journal-title":"Mol Cancer Res"},{"key":"1922_CR80","doi-asserted-by":"publisher","first-page":"e7198","DOI":"10.1161\/CIRCHEARTFAILURE.120.007198","volume":"13","author":"T Bekfani","year":"2020","unstructured":"Bekfani T, Bekhite EM, Derlien S, Nisser J, Westermann M, Nietzsche S, et al. Skeletal muscle function, structure, and metabolism in patients with heart failure with reduced ejection fraction and heart failure with preserved ejection fraction. Circ-Heart Fail. 2020;13:e7198.","journal-title":"Circ-Heart Fail"},{"key":"1922_CR81","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11010-005-2411-y","volume":"275","author":"TL Hilder","year":"2005","unstructured":"Hilder TL, Carlson GM, Haystead TA, Krebs EG, Graves LM. Caspase-3 dependent cleavage and activation of skeletal muscle phosphorylase b kinase. Mol Cell Biochem. 2005;275:233\u201342.","journal-title":"Mol Cell Biochem"},{"key":"1922_CR82","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1002\/jcsm.12784","volume":"12","author":"C Liu","year":"2021","unstructured":"Liu C, Cheung WH, Li J, Chow SK, Yu J, Wong SH, et al. Understanding the gut microbiota and sarcopenia: a systematic review. J Cachexia Sarcopenia Muscle. 2021;12:1393\u2013407.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1922_CR83","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrendo.2015.128","volume":"11","author":"EE Canfora","year":"2015","unstructured":"Canfora EE, Jocken JW, Blaak EE. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol. 2015;11:577\u201391.","journal-title":"Nat Rev Endocrinol"},{"key":"1922_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000345969","volume":"37","author":"ND Vaziri","year":"2013","unstructured":"Vaziri ND, Yuan J, Norris K. Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease. Am J Nephrol. 2013;37:1\u20136.","journal-title":"Am J Nephrol"},{"key":"1922_CR85","doi-asserted-by":"publisher","first-page":"36618","DOI":"10.1038\/srep36618","volume":"6","author":"E Sato","year":"2016","unstructured":"Sato E, Mori T, Mishima E, Suzuki A, Sugawara S, Kurasawa N, et al. Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease. Sci Rep-Uk. 2016;6:36618.","journal-title":"Sci Rep-Uk"},{"key":"1922_CR86","doi-asserted-by":"publisher","first-page":"32084","DOI":"10.1038\/srep32084","volume":"6","author":"Y Enoki","year":"2016","unstructured":"Enoki Y, Watanabe H, Arake R, Sugimoto R, Imafuku T, Tominaga Y, et al. Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1. Sci Rep-Uk. 2016;6:32084.","journal-title":"Sci Rep-Uk"},{"key":"1922_CR87","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1681\/ASN.2012050503","volume":"24","author":"L Koppe","year":"2013","unstructured":"Koppe L, Pillon NJ, Vella RE, Croze ML, Pelletier CC, Chambert S, et al. p-Cresyl sulfate promotes insulin resistance associated with CKD. J Am Soc Nephrol. 2013;24:88\u201399.","journal-title":"J Am Soc Nephrol"},{"key":"1922_CR88","first-page":"79","volume":"10","author":"V Spustov\u00e1","year":"1987","unstructured":"Spustov\u00e1 V, Dz\u00farik R, Gerykov\u00e1 M. Hippurate participation in the inhibition of glucose utilization in renal failure. Czech Med. 1987;10:79\u201389.","journal-title":"Czech Med"},{"key":"1922_CR89","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/jcp.22569","volume":"226","author":"NK Lee","year":"2011","unstructured":"Lee NK, MacLean HE. Polyamines, androgens, and skeletal muscle hypertrophy. J Cell Physiol. 2011;226:1453\u201360.","journal-title":"J Cell Physiol"},{"key":"1922_CR90","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/jcsm.12362","volume":"10","author":"HJ Chen","year":"2019","unstructured":"Chen HJ, Wang CC, Chan DC, Chiu CY, Yang RS, Liu SH. Adverse effects of acrolein, a ubiquitous environmental toxicant, on muscle regeneration and mass. J Cachexia Sarcopenia Muscle. 2019;10:165\u201376.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1922_CR91","doi-asserted-by":"publisher","first-page":"622","DOI":"10.15252\/emmm.201607052","volume":"9","author":"JF Ma","year":"2017","unstructured":"Ma JF, Sanchez BJ, Hall DT, Tremblay AK, Di Marco S, Gallouzi IE. STAT3 promotes IFN\u03b3\/TNF\u03b1-induced muscle wasting in an NF-\u03baB-dependent and IL-6-independent manner. Embo Mol Med. 2017;9:622\u201337.","journal-title":"Embo Mol Med"},{"key":"1922_CR92","doi-asserted-by":"publisher","first-page":"e146882","DOI":"10.1371\/journal.pone.0146882","volume":"11","author":"SL Passey","year":"2016","unstructured":"Passey SL, Bozinovski S, Vlahos R, Anderson GP, Hansen MJ. Serum amyloid a induces toll-like receptor 2-dependent inflammatory cytokine expression and atrophy in C2C12 skeletal muscle myotubes. PLoS ONE. 2016;11:e146882.","journal-title":"PLoS ONE"},{"key":"1922_CR93","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/s41591-019-0485-4","volume":"25","author":"J Scheiman","year":"2019","unstructured":"Scheiman J, Luber JM, Chavkin TA, MacDonald T, Tung A, Pham LD, et al. Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism. Nat Med. 2019;25:1104\u20139.","journal-title":"Nat Med"},{"key":"1922_CR94","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1111\/jan.14684","volume":"77","author":"Y Lu","year":"2021","unstructured":"Lu Y, Wang YJ, Lu Q. The effect of oral nutritional supplement on muscle fitness of patients undergoing dialysis: a systematic review and meta-analysis. J Adv Nurs. 2021;77:1716\u201330.","journal-title":"J Adv Nurs"},{"key":"1922_CR95","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.3390\/nu13041205","volume":"13","author":"Y Isaka","year":"2021","unstructured":"Isaka Y. Optimal protein intake in pre-dialysis chronic kidney disease patients with Sarcopenia: an overview. Nutrients. 2021;13:1205.","journal-title":"Nutrients"},{"key":"1922_CR96","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/ki.2009.260","volume":"76","author":"XH Wang","year":"2009","unstructured":"Wang XH, Du J, Klein JD, Bailey JL, Mitch WE. Exercise ameliorates chronic kidney disease-induced defects in muscle protein metabolism and progenitor cell function. Kidney Int. 2009;76:751\u20139.","journal-title":"Kidney Int"},{"key":"1922_CR97","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1681\/ASN.2017010020","volume":"29","author":"TA Ikizler","year":"2018","unstructured":"Ikizler TA, Robinson-Cohen C, Ellis C, Headley S, Tuttle K, Wood RJ, et al. Metabolic effects of diet and exercise in patients with moderate to severe CKD: a randomized clinical trial. J Am Soc Nephrol. 2018;29:250\u20139.","journal-title":"J Am Soc Nephrol"},{"key":"1922_CR98","first-page":"355","volume":"86","author":"P Dandona","year":"2001","unstructured":"Dandona P, Mohanty P, Ghanim H, Aljada A, Browne R, Hamouda W, et al. The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J Clin Endocr Metab. 2001;86:355\u201362.","journal-title":"J Clin Endocr Metab"},{"key":"1922_CR99","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1096\/fj.10-176917","volume":"25","author":"L Zhang","year":"2011","unstructured":"Zhang L, Rajan V, Lin E, Hu Z, Han HQ, Zhou X, et al. Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease. Faseb J. 2011;25:1653\u201363.","journal-title":"Faseb J"},{"key":"1922_CR100","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/mus.25268","volume":"55","author":"C Campbell","year":"2017","unstructured":"Campbell C, McMillan HJ, Mah JK, Tarnopolsky M, Selby K, McClure T, et al. Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: results of a randomized, placebo-controlled clinical trial. Muscle Nerve. 2017;55:458\u201364.","journal-title":"Muscle Nerve"},{"key":"1922_CR101","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2215\/CJN.04150415","volume":"11","author":"SM Deger","year":"2016","unstructured":"Deger SM, Hung AM, Ellis CD, Booker C, Bian A, Chen G, et al. High dose omega-3 fatty acid administration and skeletal muscle protein turnover in maintenance hemodialysis patients. Clin J Am Soc Nephro. 2016;11:1227\u201335.","journal-title":"Clin J Am Soc Nephro"},{"key":"1922_CR102","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/ejcn.2011.210","volume":"66","author":"S Almoosawi","year":"2012","unstructured":"Cancello R, Turroni S, Rampelli S, Cattaldo S, Candela M, Cattani L, et al. Effect of short-term dietary intervention and probiotic mix supplementation on the gut microbiota of elderly obese women. Nutrients. 2019;11:3011.","journal-title":"Eur J Clin Nutr"},{"key":"1922_CR103","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.3390\/nu11123011","volume":"11","author":"R Cancello","year":"2019","unstructured":"Buigues C, Fern\u00e1ndez-Garrido J, Pruimboom L, Hoogland AJ, Navarro-Mart\u00ednez R, Mart\u00ednez-Mart\u00ednez M, et al. Effect of a prebiotic formulation on frailty syndrome: a randomized, double-blind clinical trial. Int J Mol Sci. 2016;17:932.","journal-title":"Nutrients"},{"key":"1922_CR104","first-page":"E956","volume":"316","author":"T Okamoto","year":"2019","unstructured":"Huang WC, Lee MC, Lee CC, Ng KS, Hsu YJ, Tsai TY, et al. Effect of lactobacillus plantarum TWK10 on exercise physiological adaptation, performance, and body composition in healthy humans. Nutrients. 2019;11:2836.","journal-title":"Am J Physiol-Endoc M"},{"key":"1922_CR105","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.tem.2016.08.003","volume":"27","author":"TW Hand","year":"2016","unstructured":"Yamamoto S, Kazama JJ, Omori K, Matsuo K, Takahashi Y, Kawamura K, et al. Continuous reduction of protein-bound uraemic toxins with improved oxidative stress by using the oral charcoal adsorbent AST-120 in haemodialysis patients. Sci Rep-Uk. 2015;5:14381.","journal-title":"Trends Endocrin Met"},{"key":"1922_CR106","doi-asserted-by":"publisher","first-page":"932","DOI":"10.3390\/ijms17060932","volume":"17","author":"C Buigues","year":"2016","unstructured":"Okamoto T, Morino K, Ugi S, Nakagawa F, Lemecha M, Ida S, et al. Microbiome potentiates endurance exercise through intestinal acetate production. Am J Physiol-Endoc M. 2019;316:E956\u2013E966.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"1922_CR107","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3390\/nu16091323","volume":"16","author":"RA Fielding","year":"2024","unstructured":"Yang J, Li Q, Henning SM, Zhong J, Hsu M, Lee R, et al. Effects of prebiotic fiber xylooligosaccharide in adenine-induced nephropathy in mice. Mol Nutr Food Res. 2018;62:e1800014.","journal-title":"Nutrients"},{"key":"1922_CR108","doi-asserted-by":"publisher","first-page":"e1800014","DOI":"10.1002\/mnfr.201800014","volume":"62","author":"J Yang","year":"2018","unstructured":"Liu X, Zhang M, Wang X, Liu P, Wang L, Li Y, et al. Fecal microbiota transplantation restores normal fecal composition and delays malignant development of mild chronic kidney disease in rats. Front Microbiol. 2022;13:1037257.","journal-title":"Mol Nutr Food Res"},{"key":"1922_CR109","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","volume":"11","author":"C Hill","year":"2014","unstructured":"Nishikawa M, Ishimori N, Takada S, Saito A, Kadoguchi T, Furihata T, et al. AST-120 ameliorates lowered exercise capacity and mitochondrial biogenesis in the skeletal muscle from mice with chronic kidney disease via reducing oxidative stress. Nephrol Dial Transpl. 2015;30:934Y\u2013942.","journal-title":"Nat Rev Gastro Hepat"},{"key":"1922_CR110","doi-asserted-by":"publisher","first-page":"e13270","DOI":"10.14814\/phy2.13270","volume":"5","author":"KH Collins","year":"2017","unstructured":"Almoosawi S, Winter J, Prynne CJ, Hardy R, Stephen AM. Daily profiles of energy and nutrient intakes: are eating profiles changing over time? Eur J Clin Nutr. 2012;66:678\u2013686.","journal-title":"Physiol Rep"},{"key":"1922_CR111","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.3390\/nu11112836","volume":"11","author":"WC Huang","year":"2019","unstructured":"Hand TW, Vujkovic-Cvijin I, Ridaura VK, Belkaid Y. Linking the microbiota, chronic disease, and the immune system. Trends Endocrin Met. 2016;27:831\u2013843.","journal-title":"Nutrients"},{"key":"1922_CR112","first-page":"326","volume":"59","author":"G Tang","year":"2020","unstructured":"Fielding RA, Lustgarten MS. Impact of a whole-food, high-soluble fiber diet on the gut-muscle axis in aged mice. Nutrients. 2024;16(9):1323.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"1922_CR113","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1001\/jama.2017.17077","volume":"318","author":"D Kao","year":"2017","unstructured":"Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Expert consensus document. The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastro Hepat. 2014;11:506\u2013514.","journal-title":"Jama-J Am Med Assoc"},{"key":"1922_CR114","doi-asserted-by":"publisher","first-page":"1037257","DOI":"10.3389\/fmicb.2022.1037257","volume":"13","author":"X Liu","year":"2022","unstructured":"Collins KH, Hart DA, Smith IC, Issler AM, Reimer RA, Seerattan RA, et al. Acute and chronic changes in rat soleus muscle after high-fat high-sucrose diet. Physiol Rep. 2017;5:e13270.","journal-title":"Front Microbiol"},{"key":"1922_CR115","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1053\/j.ajkd.2005.12.036","volume":"47","author":"G Schulman","year":"2006","unstructured":"Tang G, Du Y, Jia JS, Yuan WJ. The influence of gut microbiota on skeletal muscle metabolism in patients with chronic kidney disease and intervention strategies. Zhonghua Nei Ke Za Zhi. 2020;59:326\u2013328.","journal-title":"Am J Kidney Dis"},{"key":"1922_CR116","doi-asserted-by":"publisher","first-page":"676345","DOI":"10.3389\/fphar.2021.676345","volume":"12","author":"PY Su","year":"2021","unstructured":"Kao D, Roach B, Silva M, Beck P, Rioux K, Kaplan GG, et al. Effect of oral capsule- vs colonoscopy-delivered fecal microbiota transplantation on recurrent clostridium difficile infection: a randomized clinical trial. Jama-J Am Med Assoc. 2017;318:1985\u20131993.","journal-title":"Front Pharmacol"},{"key":"1922_CR117","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1093\/ndt\/gfv103","volume":"30","author":"M Nishikawa","year":"2015","unstructured":"Schulman G, Agarwal R, Acharya M, Berl T, Blumenthal S, Kopyt N. A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD. Am J Kidney Dis. 2006;47:565\u2013577.","journal-title":"Nephrol Dial Transpl"},{"key":"1922_CR118","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1159\/000351171","volume":"37","author":"ND Vaziri","year":"2013","unstructured":"Su PY, Lee YH, Kuo LN, Chen YC, Chen C, Kang YN, et al. Efficacy of AST-120 for patients with chronic kidney disease: a network meta-analysis of randomized controlled trials. Front Pharmacol. 2021;12:676345.","journal-title":"Am J Nephrol"},{"key":"1922_CR119","doi-asserted-by":"publisher","first-page":"14381","DOI":"10.1038\/srep14381","volume":"5","author":"S Yamamoto","year":"2015","unstructured":"Vaziri ND, Yuan J, Khazaeli M, Masuda Y, Ichii H, Liu S. Oral activated charcoal adsorbent (AST-120) ameliorates chronic kidney disease-induced intestinal epithelial barrier disruption. Am J Nephrol. 2013;37:518\u2013525.","journal-title":"Sci Rep-Uk"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01922-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-024-01922-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01922-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T05:04:26Z","timestamp":1732165466000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-024-01922-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":119,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1922"],"URL":"https:\/\/doi.org\/10.1186\/s12964-024-01922-1","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]},"assertion":[{"value":"22 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"558"}}